IL2 and neoplasm: Mechanistically, mid- and high-dose RHWPs were found to collectively promote the anti-tumor immune response by increasing TNF-α, IFN-γ, and IL-2 secretion; T and B cell proliferation; and NK and macrophage effector functions.